热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-mouse/human CD44 Antibody
产品名称：
FITC anti-mouse/human CD44 Antibody
产品类别：
抗体
产品编号：
103021
产品应用：
103021
[价格]
规格 价格 库存
25tests ￥ 504 1

产品详情

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
?g sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
test size: lot-specific; ?g size: 0.5 mg/ml
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the ?g size, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for?immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References

(PubMed link indicates BioLegend citation)
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  24. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  2. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  3. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  4. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  5. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  6. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  7. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  8. Israelow B, et al. 2020. bioRxiv. . PubMed
  9. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  10. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  11. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  12. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  13. Dong L, et al. 2021. Cancer Cell. . PubMed
  14. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  15. Wang D, et al. 2018. Immunity. 48:659. PubMed
  16. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  17. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  18. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  19. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  20. Diao L, et al. 2022. iScience. 25:105511. PubMed
  21. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  22. Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
  23. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  24. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  25. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  26. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  27. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  28. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  29. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  30. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  31. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  32. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  33. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  34. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  35. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  36. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  37. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  38. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  39. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  40. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  41. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  42. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  43. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  44. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  45. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  46. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  47. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  48. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  49. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  50. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  51. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  52. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  53. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  54. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  55. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  56. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  57. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  58. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  59. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  60. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  61. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  62. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  63. Wan X, et al. 2018. Nature. 560:107. PubMed
  64. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  65. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  66. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  67. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  68. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  69. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  70. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  71. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  72. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  73. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  74. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  75. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  76. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  77. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  78. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  79. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  80. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  81. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  82. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  83. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  84. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  85. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  86. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  87. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  88. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  89. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  90. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  91. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  92. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  93. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  94. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  95. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  96. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  97. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  98. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  99. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  100. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  101. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  102. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  103. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  104. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  105. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  106. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  107. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  108. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  109. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  110. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  111. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  112. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  113. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  114. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  115. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  116. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  117. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  118. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  119. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  120. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  121. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  122. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  123. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  124. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  125. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  126. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
RRID
AB_493684 (BioLegend Cat. No. 103021) AB_312956 (BioLegend Cat. No. 103005) AB_312957 (BioLegend Cat. No. 103006) AB_493685 (BioLegend Cat. No. 103022)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线